A fertility product that claims to be 99% accurate is the latest project to seek investment via crowd-funding platform SyndicateRoom.
Fertility Focus are aiming to raise £275,000 in return for 6.32% equity in the business. Their product, Ovusense, is a real-time ovulation monitor that is able to predict the onset of ovulation a day in advance, and confirm the exact date of ovulation; th eonly product on the market able to do this.
The Company has a small but extremely rounded team with expertise in consumer digital marketing, high volume medical devices, women’s health and intellectual property development. The CEO Robert Milnes has a sales and marketing background, as well as years in the industry financing and developing healthcare products. Chairman Steve Godber was the lead investor in last round of funding, and has 25 years of healthcare experience; others in the team include a dedicated commercial manager and nurse consultant, ensuring that all areas of the company are covered.
CEO Robert Milnes said: “We’re delighted to be helping couples that have sometimes struggled with infertility for years to become pregnant. Our next generation product will open that opportunity to an even wider audience.”